We have access to serum samples via my mentor Jean-Frederic Colombel -- who is the PI [principal investigator] of the PREDICTS study-- up to 10 years before Crohn's disease or ulcerative colitis ...

Addressing all aspects of healthcare maintenance in ulcerative colitis (UC) — one of two major types of inflammatory bowel ...

Notable news about inflammatory bowel disease (IBD) in 2024 included a study evaluating loss of response to tumor necrosis ...

July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide. The benefits of current medications are limited by problematic ...

By combining 25 datasets, researchers have created the largest cohesive cell atlas of the human gut and uncovered a new way that stomach cells may play a role in Inflammatory Bowel Disease.

The prevalence of inflammatory bowel disease in U.S. children under 20 is increasing, with over 100,000 affected, revealing ...

The new ulcerative colitis (UC) triumvirate in Johnson & Johnson ... looks to distinguish itself with an on-body injector ...

Johnson & Johnson seeks US FDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis: Spring House, Pennsylvania Monday, November 25, 2024, 11:00 Hrs [IST] ...

New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), ...

Researchers at Duke University School of Medicine have found that tapping into the nervous system could help reduce the gut ...

Prevalence and Market Potential in Europe GERD, Crohn’s Disease and Ulcerative Colitis represent significant worldwide healthcare challenges across Europe. GERD: The GERD treatment market in ...